相关实验视频

Updated: Jun 25, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

在瘤母体体中准目标,以促进癌症治疗反应

Siti Munira Abd Jalil¹, Jack C Henry¹, Angus J M Cameron¹

¹Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK.

|May 25, 2024

概括

细胞外基质 (ECM) 或基质体在瘤进展和治疗耐药性方面发挥着复杂的作用. 准母体组件为改善晚期癌症治疗反应提供了潜在的治疗机会.

科学领域:

在瘤学瘤学.
生物化学生物化学
癌症生物学癌症生物学

背景情况:

细胞外基质 (ECM) 是由包括癌细胞在内的各种细胞产生的蛋白质和宏分子的复杂网络.
瘤进展和转移涉及ECM组成和组织的动态变化.
固体瘤中密集,纤维化的ECM通常与药物递送减少和免疫细胞透受损有关,可能阻碍治疗反应.

研究的目的:

审查与晚期瘤和治疗耐药性相关的关键母体组件.
探索针对母体组分的潜力,作为一种治疗策略,以增强现有的癌症治疗方法.
了解不同的母体组分如何影响瘤表型和治疗结果.

主要方法:

对科学文献的审查,重点关注癌症中的母体体.
对调查单个ECM组件功能的研究进行分析.
检查针对母体体的治疗干预措施.

主要成果:

孕细胞体表现出复杂的作用,充当瘤抑制剂和促进剂,并调节免疫反应.
准单个母体组分已经显示出多样化,有时复杂的临床翻译.
矩阵签名可以预测患者的预后,免疫细胞透和对免疫治疗的反应.

结论:

了解ECM复杂的机制对于确定新的治疗点至关重要.
通过向母体体来修改瘤微环境,有望提高癌症治疗效率.
对ECM的生物化学和生物物理性质的进一步研究可以打开打击瘤进展和抵抗的新策略.

关键词:

抗瘤免疫力抗瘤免疫力与癌症相关的纤维细胞.细胞外矩阵是细胞外矩阵.免疫疗法免疫疗法肌肉干支 (Stroma) 是一种干支.有针对性的治疗.瘤母体细胞组中的瘤微环境是一个微环境.

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...